Latest Blogs

May 22, 2019
Breakthrough will bring together unique experts in the field, including innovators, scientists, and technology specialists, all to discuss better solutions for cancer care, writes ASCO president-elect Dr. Howard A. "Skip" Burris.
May 20, 2019
Health Equity Committee chair Dr. William D. Tap highlights the recent work and forward momentum of ASCO's efforts to achieve health care equity for all through improved access to and quality of care.
May 20, 2019
Dr. Ward and I discuss the policies that public and private insurers use to control the use of anticancer drug therapies, such as prior authorization requirements, restrictive formularies, step therapy, or fail first requirements, and specialty specific tiers.
May 17, 2019
To help you get the most out of #ASCO19, I'm sharing a vlog on networking (it's not as scary as you think!) and strategies for organizing your schedule and maximizing your face time with the people you want to meet.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the Medical Director for the Cancer Care Partnership with Penn State University Cancer Institute and Professor of Medicine Penn State Hershey Cancer Institute. He currently serves as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is also Past President of the Pennsylvania Society of Oncology and Hematology and the delegate representing ASCO at the AMA-House of Delegates.

Sep 23, 2013
It has been a couple of weeks since our visitor has left, but it remains a visit that should be shared. The International Development and Education Award (...
Jul 02, 2013
I just returned from an interesting family weekend. This family was the American Medical Association House of Delegates (AMA-HOD). I, along with Drs. Chris Nunnick, Barb McAneny, and ASCO staff, have had the pleasure of attending these meetings as a representative of ASCO for the past few years. It...
May 05, 2010
It seems like I've participated in every facet of the "ASCO guideline" process. During the past three years of being part of the HSC (now CPG) committee, I have been amazed to witness how complex and detailed developing a guideline can become. The manuscripts are reviewed at several levels and...

Pages